Bacterial adhesion to uroepithelial cell

Bacterial adhesion to uroepithelial cells is not a single molecule or receptor but rather describes the process by which bacteria—most notably Escherichia coli—attach themselves to the epithelial lining of the urinary tract. This step is critical for initiating urinary tract infections (UTIs). The process involves multiple molecular interactions between bacterial surface structures called adhesins (such as type 1 and P fimbriae) and specific carbohydrate-containing receptors on the host's uroepithelial cells. Sialic acid residues and other glycoconjugates on these cells play an important role in mediating this adherence. Disrupting this interaction is a therapeutic strategy for preventing UTIs, with agents like D-mannose and cranberry-derived compounds shown experimentally or clinically to reduce bacterial binding by interfering with these molecular contacts[2][4][5][7][8]. However, "bacterial adhesion to uroepithelial cell" itself is not a canonical drug target but rather describes an infectious mechanism involving several potential targets. This entry does not refer to a single protein, gene, receptor, enzyme, transporter, etc., but instead describes an entire pathogenic mechanism involving multiple molecules from both bacteria (e.g., FimH adhesin) and host (e.g., uroplakin glycoproteins). Therefore: is_incorrect: true — because it does not specify one canonical target molecule/receptor suitable for structured pharmacological databases.

Inhibition of bacterial adhesins such as type 1 fimbriae/FimH and P fimbriae/PapG to prevent attachment to uroepithelial cells[2][8]. Blocking bacterial binding sites on the host cell surface glycoconjugates, including sialic acid and mannose residues[2][7].